ProMetic and Serono Sign a Development and Collaboration Agreement
Development revenues for ProMetic of up to £550,000 (approx. $C1.3M)
15-Mar-2004 -
Montreal, Canada. ProMetic Life Sciences Inc. wholly owned
subsidiary ProMetic Biosciences Ltd announced that it has signed a development and
collaboration agreement with Laboratories Serono S.A. to provide
Serono access to ProMetic´s unique protein purification technology.
Serono will fund the ...
laboratories
plasma
protein purification
+1